Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Clinical Trials01:16

Clinical Trials

8.5K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
8.5K
COPD: Management Using Bronchodilators and Corticosteroids01:26

COPD: Management Using Bronchodilators and Corticosteroids

1.2K
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
1.2K
Pneumonia IV: Management01:28

Pneumonia IV: Management

1.2K
The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
1.2K
Clinical Trials: Overview01:11

Clinical Trials: Overview

4.7K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
4.7K
Drugs Used in Lower Respiratory Disorders: Overview01:17

Drugs Used in Lower Respiratory Disorders: Overview

1.6K
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
1.6K
Inhaled Medications01:23

Inhaled Medications

1.1K
Inhaled medications are crucial for managing chronic obstructive pulmonary disease (COPD) and asthma. They are essential for effective treatment and control, ensuring optimal respiratory health and well-being. Inhaled medication delivers drugs directly to the lungs, providing a rapid onset of action and reducing systemic side effects compared to oral or injectable medications. Three primary types of inhalation devices are used to administer these medications: nebulizers, metered-dose inhalers...
1.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

CT assessment of body composition and lung evolution in cystic fibrosis after Elexacaftor-Tezacaftor-Ivacaftor: A cohort study.

Respiratory medicine·2026
Same author

Distinctive Inflammatory Proteomic Profile of HIV-1 Elite Controllers: A Comparative Study in a Spanish Cohort.

Journal of medical virology·2026
Same author

Bone Structural Parameters in Adults with Cystic Fibrosis: Contribution of Adherence to the Mediterranean Diet.

Journal of clinical medicine·2026
Same author

Biomechanical assessment of dressage Spanish horses through accelerometry and the immediate effects of a single capacitive resistive electrical transfer session.

BMC veterinary research·2026
Same author

Respiratory Syncytial Virus and COVID-19 in Hospitalized Adults in Spain: Clinical, Radiological Features and Antimicrobial Use.

Immunity, inflammation and disease·2025
Same author

What is the optimal dose of N-acetylcysteine in adult patients with bronchiectasis?-data from the RIBRON registry.

Journal of thoracic disease·2025

Related Experiment Videos

Nebulized therapy. SEPAR year.

Casilda Olveira1, Ana Muñoz2, Adolfo Domenech2

  • 1UGC de Enfermedades Respiratorias, Hospital Regional Universitario de Málaga, Instituto de Biomedicina de Málaga (IBIMA), Facultad de Medicina, Universidad de Málaga, Málaga, España.

Archivos De Bronconeumologia
|July 6, 2014
PubMed
Summary

Nebulized inhaled drugs offer targeted respiratory treatment with faster action and fewer side effects. Advancements in nebulizer technology improve drug delivery and treatment efficiency for various respiratory medications.

Keywords:
Antibióticos nebulizadosBronchodilatorsBroncodilatadoresMucolíticos nebulizadosNebulizadoresNebulized antibioticsNebulized mucolyticsNebulized therapyNebulizersTerapia nebulizada

Related Experiment Videos

Area of Science:

  • Pulmonology
  • Pharmacology
  • Respiratory Medicine

Background:

  • Inhaled drugs provide direct respiratory tract deposition, leading to higher concentrations, rapid onset, and reduced systemic side effects compared to systemic administration.
  • Nebulization is crucial for high-dose bronchodilators, specific medications like antibiotics or dornase alfa, and patients unable to use other inhalation devices.

Purpose of the Study:

  • To review current and investigational nebulized drugs for adult patients.
  • To highlight advancements in nebulizer technology for optimized pulmonary drug delivery.

Main Methods:

  • Literature review focusing on drugs used or under investigation for nebulization in adults.
  • Analysis of drug classes including bronchodilators, inhaled steroids, antibiotics, antifungals, mucolytics, anticoagulants, prostanoids, and lidocaine.

Main Results:

  • Nebulized drugs offer targeted delivery, enhancing efficacy and minimizing side effects.
  • Technological innovations are improving pulmonary deposition and reducing treatment duration.
  • A wide range of therapeutic agents are available or being developed for nebulization.

Conclusions:

  • Nebulization remains a vital route for specific respiratory conditions and patient populations.
  • Ongoing technological advancements promise more efficient and effective inhaled therapies.
  • The scope of nebulized medications continues to expand, offering broader treatment options.